Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymidine kinase: diagnostic and prognostic potential.

K L O'Neill1, M R Buckwalter, B K Murray

  • 1Department of Microbiology, Brigham Young University, Provo, UT, USA. kim_oneil@byu.edu

Expert Review of Molecular Diagnostics
|March 21, 2002
PubMed
Summary

Thymidine kinase, a cancer marker, can be detected in serum and tumor tissue. A new, low-cost assay shows promise for cancer detection and monitoring treatment effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bax/Bak activation in the absence of Bid, Bim, Puma, and p53.

Cell death & disease·2016
Same author

Thymidine kinase 1--a prognostic and diagnostic indicator in ALL and AML patients.

Leukemia·2007
Same author

Critical parameters influencing hyperthermia-induced apoptosis in human lymphoid cell lines.

Apoptosis : an international journal on programmed cell death·2003
Same author

Cell cycle arrest and differential gene expression in HT-29 cells exposed to an aqueous garlic extract.

Nutrition and cancer·2001
Same author

A monoclonal antibody specific for human thymidine kinase 1.

Hybridoma·2001
Same author

Thymidine kinase 1 immunoassay: a potential marker for breast cancer.

Cancer detection and prevention·2001

Area of Science:

  • Biochemistry
  • Oncology
  • Immunology

Background:

  • Thymidine kinase (TK) is a cell cycle-dependent enzyme.
  • Elevated serum TK levels are observed in various cancers and correlate with disease progression and treatment response.
  • Current detection methods may be limited in scope or cost-effectiveness.

Purpose of the Study:

  • To introduce a novel monoclonal antibody-based assay for thymidine kinase detection.
  • To evaluate the utility of this assay in both serum and tumor tissue samples.
  • To assess the potential of a low-cost thymidine kinase assay for cancer diagnostics.

Main Methods:

  • Development of a new monoclonal antibody assay targeting thymidine kinase.
  • Application of the assay to detect thymidine kinase in patient serum.
  • Application of the assay to detect thymidine kinase in tumor tissue specimens.

Main Results:

  • The developed assay successfully detects thymidine kinase in both serum and tumor tissue.
  • Serum thymidine kinase levels reflect cancer progression and therapeutic efficacy.
  • The assay demonstrates potential for broad application across various cancer types.

Conclusions:

  • A new, cost-effective monoclonal antibody assay for thymidine kinase has been developed.
  • This assay can detect thymidine kinase in serum and tumor tissue, aiding cancer detection and monitoring.
  • Low-cost thymidine kinase assays hold significant potential for improving cancer management strategies.

Related Experiment Videos